Free Trial
→ Secret financial plot unfolding in Washington DC… [DEVELOPING] (From Timothy Sykes) (Ad) Free MNPR Stock Alerts

Monopar Therapeutics (MNPR) SEC Filings & 10K Form

Monopar Therapeutics logo
$40.25 -0.72 (-1.76%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$40.58 +0.33 (+0.81%)
As of 02/21/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Monopar Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
5:25 PM		Monopar Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/12/2025
8:45 AM		Adage Capital Management, L.P. (Filed by)
Monopar Therapeutics (Subject)
Form SCHEDULE 13G
02/07/2025
4:01 PM		Gem Pharmaceuticals LLC (Subject)
Monopar Therapeutics (Filed by)
Form SCHEDULE 13D/A
01/27/2025
11:15 PM		Monopar Therapeutics (Filer)
Form EFFECT
01/27/2025
4:19 PM		Monopar Therapeutics (Filer)
Form 424B3
01/15/2025
4:01 PM		Monopar Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2025
10:38 AM		JANUS HENDERSON GROUP PLC (Filed by)
Monopar Therapeutics (Subject)
Form SCHEDULE 13G/A
01/02/2025
5:14 PM		Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
5:15 PM		Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
5:16 PM		Monopar Therapeutics (Issuer)
RIOUX PATRICE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:06 PM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
5:01 AM		Monopar Therapeutics (Filer)
Form 424B5
12/18/2024
4:01 PM		Monopar Therapeutics (Filer)
Form 424B3
12/17/2024
11:15 PM		Monopar Therapeutics (Filer)
Form EFFECT
12/06/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
4:01 PM		Monopar Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/08/2024
7:02 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:01 AM		Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
2:13 PM		JANUS HENDERSON GROUP PLC (Filed by)
Monopar Therapeutics (Subject)
Form SC 13G
10/31/2024
3:17 PM		Monopar Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
10/28/2024
3:04 PM		Monopar Therapeutics (Filer)
Form 424B5
10/28/2024
5:00 AM		ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
Monopar Therapeutics (Subject)
Form SC 13G
10/24/2024
3:08 PM		Monopar Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
10/24/2024
6:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
6:45 PM		Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:44 PM		Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:07 PM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:01 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:02 AM		Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2024
6:00 AM		Monopar Therapeutics (Filer)
Form DEF 14A
07/22/2024
6:01 AM		Monopar Therapeutics (Filer)
Form ARS
07/11/2024
3:30 PM		Monopar Therapeutics (Filer)
Form PRE 14A
07/09/2024
3:01 PM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
5:20 PM		Monopar Therapeutics (Issuer)
Radhakrishnan Karthik (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2024
5:22 PM		Monopar Therapeutics (Issuer)
Radhakrishnan Karthik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
“Amazon Coin” set to outperform Bitcoin (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…

#1 FREE Crypto for 2025
07/02/2024
5:07 PM		Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
5:08 PM		Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
5:12 PM		Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:16 PM		Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:08 PM		Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:30 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
5:12 PM		Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:56 PM		Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:10 PM		Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:00 AM		Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
7:33 PM		Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:33 PM		Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:35 PM		Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
6:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
6:01 AM		Monopar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2024
7:30 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
6:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
12:45 PM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
5:59 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:00 AM		Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:MNPR) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED
Robert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...
NewMarket Health Publishing, LLC. | Sponsored
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
What is this southern state hiding?
The financial press had a field day this week after President Donald Trump and Department of Government Effici...
Stansberry Research | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored